AFFINITY ASSET ADVISORS, LLC Holdings

AFFINITY ASSET ADVISORS, LLC is an investment fund managing more than 358.28M US dollars. The largest holdings include SPDR S&P 500 ETF Trust, Establishment Labs Holdings and Chinook Therapeutics. In Q3 2022 the fund bought assets of total value of 69.67M US dollars and sold assets of total value of 36.82M US dollars.

$358.27M

portfolio value

+4.07%

quarter

-49.49%

1 year

AFFINITY ASSET ADVISORS, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2021	98181000	26259000
Q2 2021	45102000	24719000
Q3 2021	74369000	30541000
Q4 2021	67675000	76380000
Q1 2022	71395000	55748000
Q2 2022	19884000	84043000
Q3 2022	69667000	36815000

AFFINITY ASSET ADVISORS, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
SPDR S&P 500 ETF Trust Portfolio share: 24.92% Portfolio value: 89.29M Avg. open price: $370.23 Current price: $400.01 P/L: +8.04% N/A Q3 2022	put	24.92%	89.29M	$370.23	$400.01	+8.04%	N/A Q3 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 4.98% Portfolio value: 17.83M Avg. open price: $69.05 Current price: $68.77 P/L: -0.40% Sold -9.25% shares Q3 2022	share	4.98%	17.83M	$69.05	$68.77	-0.40%	Sold -9.25% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 4.47% Portfolio value: 16.00M Avg. open price: $14.36 Current price: $22.77 P/L: +58.58% Sold -13.18% shares Q3 2022	share	4.47%	16.00M	$14.36	$22.77	+58.58%	Sold -13.18% shares Q3 2022
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 3.61% Portfolio value: 12.93M Avg. open price: $35.02 Current price: $68.49 P/L: +95.57% N/A Q3 2022	share	3.61%	12.93M	$35.02	$68.49	+95.57%	N/A Q3 2022
iShares Russell 2000 ETF Portfolio share: 3.22% Portfolio value: 11.54M Avg. open price: N/A Current price: $182.83 P/L: N/A N/A Q3 2022	put	3.22%	11.54M	N/A	$182.83	N/A	N/A Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 3.18% Portfolio value: 11.40M Avg. open price: N/A Current price: $44.93 P/L: N/A N/A Q3 2022	share	3.18%	11.40M	N/A	$44.93	N/A	N/A Q3 2022
TRAVERE THERAPEUTICS INC Portfolio share: 3.11% Portfolio value: 11.13M Avg. open price: N/A Current price: N/A P/L: N/A Bought +57.14% shares Q1 2022	share	3.11%	11.13M	N/A	N/A	N/A	Bought +57.14% shares Q1 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 2.88% Portfolio value: 10.32M Avg. open price: $140.59 Current price: $119.41 P/L: -15.06% Sold -20.06% shares Q3 2022	share	2.88%	10.32M	$140.59	$119.41	-15.06%	Sold -20.06% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 2.65% Portfolio value: 9.50M Avg. open price: N/A Current price: $44.93 P/L: N/A N/A Q3 2022	put	2.65%	9.50M	N/A	$44.93	N/A	N/A Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 2.58% Portfolio value: 9.23M Avg. open price: $19.67 Current price: $15.82 P/L: -19.56% Sold -27.20% shares Q3 2022	share	2.58%	9.23M	$19.67	$15.82	-19.56%	Sold -27.20% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 2.55% Portfolio value: 9.14M Avg. open price: $55.31 Current price: $56.01 P/L: +1.27% Sold -7.14% shares Q3 2022	share	2.55%	9.14M	$55.31	$56.01	+1.27%	Sold -7.14% shares Q3 2022
Medical Devices Inari Medical, Inc. Portfolio share: 2.43% Portfolio value: 8.71M Avg. open price: $93.95 Current price: $71.11 P/L: -24.31% Sold -45.99% shares Q3 2022	share	2.43%	8.71M	$93.95	$71.11	-24.31%	Sold -45.99% shares Q3 2022
NANOSTRING TECHNOLOGIES INC Portfolio share: 2.38% Portfolio value: 8.54M Avg. open price: N/A Current price: N/A P/L: N/A Bought +42.86% shares Q2 2022	share	2.38%	8.54M	N/A	N/A	N/A	Bought +42.86% shares Q2 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 2.30% Portfolio value: 8.22M Avg. open price: $66.07 Current price: $68.42 P/L: +3.56% Bought +76.47% shares Q3 2022	share	2.30%	8.22M	$66.07	$68.42	+3.56%	Bought +76.47% shares Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 1.81% Portfolio value: 6.49M Avg. open price: $94.34 Current price: $72.87 P/L: -22.76% Bought +33.33% shares Q2 2022	share	1.81%	6.49M	$94.34	$72.87	-22.76%	Bought +33.33% shares Q2 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.66% Portfolio value: 5.93M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q3 2022	share	1.66%	5.93M	N/A	$28.09	N/A	N/A Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 1.61% Portfolio value: 5.77M Avg. open price: $6.81 Current price: $6.72 P/L: -1.32% Bought +2818.82% shares Q3 2022	share	1.61%	5.77M	$6.81	$6.72	-1.32%	Bought +2818.82% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 1.53% Portfolio value: 5.48M Avg. open price: $66.07 Current price: $68.42 P/L: +3.56% N/A Q3 2022	put	1.53%	5.48M	$66.07	$68.42	+3.56%	N/A Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 1.40% Portfolio value: 5.00M Avg. open price: $4.61 Current price: $10.02 P/L: +117.36% Sold -3.99% shares Q3 2022	share	1.40%	5.00M	$4.61	$10.02	+117.36%	Sold -3.99% shares Q3 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 1.39% Portfolio value: 4.99M Avg. open price: $70.45 Current price: $24.25 P/L: -65.58% N/A Q3 2022	share	1.39%	4.99M	$70.45	$24.25	-65.58%	N/A Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 1.36% Portfolio value: 4.87M Avg. open price: $94.34 Current price: $72.87 P/L: -22.76% N/A Q3 2022	put	1.36%	4.87M	$94.34	$72.87	-22.76%	N/A Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 1.32% Portfolio value: 4.74M Avg. open price: N/A Current price: $212 P/L: N/A N/A Q3 2022	call	1.32%	4.74M	N/A	$212	N/A	N/A Q3 2022
Biotechnology CymaBay Therapeutics, Inc. Portfolio share: 1.26% Portfolio value: 4.51M Avg. open price: $3.22 Current price: $4.17 P/L: +29.34% Sold -5.96% shares Q3 2022	share	1.26%	4.51M	$3.22	$4.17	+29.34%	Sold -5.96% shares Q3 2022
BRIDGEBIO PHARMA INC Portfolio share: 1.25% Portfolio value: 4.49M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	1.25%	4.49M	N/A	N/A	N/A	N/A Q4 2021
BRIDGEBIO PHARMA INC Portfolio share: 1.24% Portfolio value: 4.43M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	1.24%	4.43M	N/A	N/A	N/A	N/A Q1 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 1.19% Portfolio value: 4.27M Avg. open price: $27.27 Current price: $19.03 P/L: -30.22% Bought +6.92% shares Q3 2022	share	1.19%	4.27M	$27.27	$19.03	-30.22%	Bought +6.92% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 1.16% Portfolio value: 4.14M Avg. open price: $48.69 Current price: $26.56 P/L: -45.45% Sold -32.09% shares Q3 2022	share	1.16%	4.14M	$48.69	$26.56	-45.45%	Sold -32.09% shares Q3 2022
Biotechnology Arcellx, Inc. Portfolio share: 1.10% Portfolio value: 3.94M Avg. open price: $18.08 Current price: $19.45 P/L: +7.58% Bought +180.18% shares Q3 2022	share	1.10%	3.94M	$18.08	$19.45	+7.58%	Bought +180.18% shares Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 1.03% Portfolio value: 3.68M Avg. open price: $53.35 Current price: $20.26 P/L: -62.02% Bought +142.86% shares Q3 2022	share	1.03%	3.68M	$53.35	$20.26	-62.02%	Bought +142.86% shares Q3 2022
Biotechnology Astria Therapeutics, Inc. Portfolio share: 1.01% Portfolio value: 3.61M Avg. open price: N/A Current price: $10.32 P/L: N/A N/A Q3 2022	share	1.01%	3.61M	N/A	$10.32	N/A	N/A Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 1.00% Portfolio value: 3.57M Avg. open price: N/A Current price: $13.57 P/L: N/A N/A Q3 2022	share	1.00%	3.57M	N/A	$13.57	N/A	N/A Q3 2022
Shell Companies ARYA Sciences Acquisition Corp V Portfolio share: 0.97% Portfolio value: 3.46M Avg. open price: N/A Current price: $9.97 P/L: N/A Sold -49.82% shares Q2 2022	share	0.97%	3.46M	N/A	$9.97	N/A	Sold -49.82% shares Q2 2022
Drug Manufacturers—General GSK plc Portfolio share: 0.90% Portfolio value: 3.23M Avg. open price: N/A Current price: $35.16 P/L: N/A N/A Q3 2022	put	0.90%	3.23M	N/A	$35.16	N/A	N/A Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.88% Portfolio value: 3.14M Avg. open price: $28.83 Current price: $38.12 P/L: +32.20% Bought +333.33% shares Q3 2022	share	0.88%	3.14M	$28.83	$38.12	+32.20%	Bought +333.33% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 0.64% Portfolio value: 2.29M Avg. open price: $9.02 Current price: $12.5 P/L: +38.58% Bought +23.27% shares Q3 2022	share	0.64%	2.29M	$9.02	$12.5	+38.58%	Bought +23.27% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.63% Portfolio value: 2.24M Avg. open price: $34.73 Current price: $36.66 P/L: +5.57% Bought +100.00% shares Q3 2022	share	0.63%	2.24M	$34.73	$36.66	+5.57%	Bought +100.00% shares Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 0.62% Portfolio value: 2.20M Avg. open price: N/A Current price: $35.16 P/L: N/A N/A Q3 2022	share	0.62%	2.20M	N/A	$35.16	N/A	N/A Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 0.60% Portfolio value: 2.14M Avg. open price: $18.93 Current price: $15.66 P/L: -17.28% Bought +36.43% shares Q3 2022	share	0.60%	2.14M	$18.93	$15.66	-17.28%	Bought +36.43% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 0.59% Portfolio value: 2.11M Avg. open price: $55.31 Current price: $56.01 P/L: +1.27% Sold -57.14% shares Q3 2022	put	0.59%	2.11M	$55.31	$56.01	+1.27%	Sold -57.14% shares Q3 2022
Biotechnology Vincerx Pharma, Inc. Portfolio share: 0.57% Portfolio value: 2.06M Avg. open price: $14.17 Current price: $0.7 P/L: -95.06% Bought +8.64% shares Q3 2022	share	0.57%	2.06M	$14.17	$0.7	-95.06%	Bought +8.64% shares Q3 2022
Invesco CurrencyShares Euro Currency Trust Portfolio share: 0.50% Portfolio value: 1.80M Avg. open price: N/A Current price: $96.73 P/L: N/A N/A Q3 2022	put	0.50%	1.80M	N/A	$96.73	N/A	N/A Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 0.47% Portfolio value: 1.68M Avg. open price: N/A Current price: $13.57 P/L: N/A N/A Q3 2022	put	0.47%	1.68M	N/A	$13.57	N/A	N/A Q3 2022
Biotechnology Geron Corporation Portfolio share: 0.42% Portfolio value: 1.52M Avg. open price: N/A Current price: $2.29 P/L: N/A N/A Q3 2022	put	0.42%	1.52M	N/A	$2.29	N/A	N/A Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 0.41% Portfolio value: 1.47M Avg. open price: N/A Current price: $37.72 P/L: N/A N/A Q3 2022	share	0.41%	1.47M	N/A	$37.72	N/A	N/A Q3 2022
Biotechnology Geron Corporation Portfolio share: 0.41% Portfolio value: 1.46M Avg. open price: N/A Current price: $2.29 P/L: N/A N/A Q3 2022	call	0.41%	1.46M	N/A	$2.29	N/A	N/A Q3 2022
PRECIGEN INC Portfolio share: 0.41% Portfolio value: 1.45M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.41%	1.45M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 0.39% Portfolio value: 1.39M Avg. open price: $18.99 Current price: $5.17 P/L: -72.78% N/A Q3 2022	share	0.39%	1.39M	$18.99	$5.17	-72.78%	N/A Q3 2022
Biotechnology Milestone Pharmaceuticals Inc. Portfolio share: 0.35% Portfolio value: 1.26M Avg. open price: N/A Current price: $4.75 P/L: N/A N/A Q3 2022	call	0.35%	1.26M	N/A	$4.75	N/A	N/A Q3 2022
Biotechnology LianBio Portfolio share: 0.31% Portfolio value: 1.09M Avg. open price: $4.7 Current price: $1.49 P/L: -68.28% Bought +22.22% shares Q3 2022	share	0.31%	1.09M	$4.7	$1.49	-68.28%	Bought +22.22% shares Q3 2022
Invesco CurrencyShares British Pound Sterling Trust Portfolio share: 0.30% Portfolio value: 1.07M Avg. open price: N/A Current price: $116.94 P/L: N/A N/A Q3 2022	put	0.30%	1.07M	N/A	$116.94	N/A	N/A Q3 2022
Biotechnology Context Therapeutics Inc. Portfolio share: 0.27% Portfolio value: 981K Avg. open price: $2.17 Current price: $1.31 P/L: -39.63% Bought +13.64% shares Q2 2022	share	0.27%	981K	$2.17	$1.31	-39.63%	Bought +13.64% shares Q2 2022
Biotechnology Centessa Pharmaceuticals plc Portfolio share: 0.27% Portfolio value: 975K Avg. open price: N/A Current price: $3.93 P/L: N/A N/A Q3 2022	share	0.27%	975K	N/A	$3.93	N/A	N/A Q3 2022
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 0.22% Portfolio value: 792K Avg. open price: N/A Current price: $6.78 P/L: N/A N/A Q3 2022	share	0.22%	792K	N/A	$6.78	N/A	N/A Q3 2022
Biotechnology Nautilus Biotechnology, Inc. Portfolio share: 0.22% Portfolio value: 790K Avg. open price: $8.12 Current price: $1.76 P/L: -78.33% Sold -20.17% shares Q3 2022	share	0.22%	790K	$8.12	$1.76	-78.33%	Sold -20.17% shares Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.19% Portfolio value: 687K Avg. open price: N/A Current price: $21.42 P/L: N/A N/A Q3 2022	call	0.19%	687K	N/A	$21.42	N/A	N/A Q3 2022
Biotechnology Viking Therapeutics, Inc. Portfolio share: 0.19% Portfolio value: 680K Avg. open price: N/A Current price: $3.97 P/L: N/A N/A Q3 2022	share	0.19%	680K	N/A	$3.97	N/A	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.15% Portfolio value: 538K Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	call	0.15%	538K	N/A	$21.89	N/A	N/A Q3 2022
immatics biotechnologies GmbH Portfolio share: 0.14% Portfolio value: 507K Avg. open price: N/A Current price: $3.48 P/L: N/A Sold -1.47% shares Q1 2022	share	0.14%	507K	N/A	$3.48	N/A	Sold -1.47% shares Q1 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 0.14% Portfolio value: 507K Avg. open price: $19.67 Current price: $15.82 P/L: -19.56% N/A Q3 2022	put	0.14%	507K	$19.67	$15.82	-19.56%	N/A Q3 2022
Biotechnology Renovacor, Inc. Portfolio share: 0.14% Portfolio value: 503K Avg. open price: $8 Current price: $3.2 P/L: -60.00% Bought +59.59% shares Q1 2022	share	0.14%	503K	$8	$3.2	-60.00%	Bought +59.59% shares Q1 2022
Biotechnology Tango Therapeutics, Inc. Portfolio share: 0.08% Portfolio value: 297K Avg. open price: N/A Current price: $7.69 P/L: N/A N/A Q3 2022	share	0.08%	297K	N/A	$7.69	N/A	N/A Q3 2022
Vickers Vantage Corp. I Portfolio share: 0.00% Portfolio value: 17K Avg. open price: N/A Current price: $0.14 P/L: N/A N/A Q3 2022	share	0.00%	17K	N/A	$0.14	N/A	N/A Q3 2022
RENOVACOR INC Portfolio share: 0.00% Portfolio value: 6K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	6K	N/A	N/A	N/A	N/A Q3 2021
Medicus Sciences Acquisition Corp. Portfolio share: 0.00% Portfolio value: 3K Avg. open price: N/A Current price: $0.09 P/L: N/A N/A Q2 2021	share	0.00%	3K	N/A	$0.09	N/A	N/A Q2 2021
Biotechnology Moderna, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $130.95 Current price: $175.93 P/L: +34.35% Sold -100.00% shares Q3 2022	call	0.00%	0	$130.95	$175.93	+34.35%	Sold -100.00% shares Q3 2022
Biotechnology Terns Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.09 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.09	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $369.29 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$369.29	N/A	Sold -100.00% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $50.99 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$50.99	N/A	Sold -100.00% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $126.79 Current price: $226.95 P/L: +79.00% Sold -100.00% shares Q3 2022	share	0.00%	0	$126.79	$226.95	+79.00%	Sold -100.00% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $126.79 Current price: $226.95 P/L: +79.00% Sold -100.00% shares Q3 2022	put	0.00%	0	$126.79	$226.95	+79.00%	Sold -100.00% shares Q3 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $30.06 Current price: $8.03 P/L: -73.29% Sold -100.00% shares Q3 2022	call	0.00%	0	$30.06	$8.03	-73.29%	Sold -100.00% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $20.4 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$20.4	N/A	Sold -100.00% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $26.84 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$26.84	N/A	Sold -100.00% shares Q3 2022
Biotechnology Enochian Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.08 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$1.08	N/A	Sold -100.00% shares Q3 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $69.05 Current price: $68.77 P/L: -0.40% Sold -100.00% shares Q3 2022	put	0.00%	0	$69.05	$68.77	-0.40%	Sold -100.00% shares Q3 2022
Biotechnology Curis, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.83 Current price: $0.77 P/L: -90.13% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.83	$0.77	-90.13%	Sold -100.00% shares Q3 2022
Biotechnology Celularity Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.71 Current price: $1.69 P/L: -80.60% Sold -100.00% shares Q3 2022	put	0.00%	0	$8.71	$1.69	-80.60%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $105.21 Current price: $98.48 P/L: -6.40% Sold -100.00% shares Q3 2022	share	0.00%	0	$105.21	$98.48	-6.40%	Sold -100.00% shares Q3 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $62.77 Current price: $52.11 P/L: -16.98% Sold -100.00% shares Q3 2022	call	0.00%	0	$62.77	$52.11	-16.98%	Sold -100.00% shares Q3 2022
Biotechnology Repare Therapeutics Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $21.25 Current price: $16.49 P/L: -22.40% Sold -100.00% shares Q3 2022	share	0.00%	0	$21.25	$16.49	-22.40%	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $34.73 Current price: $36.66 P/L: +5.57% Sold -100.00% shares Q3 2022	call	0.00%	0	$34.73	$36.66	+5.57%	Sold -100.00% shares Q3 2022
Biotechnology Novavax, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $17.61 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$17.61	N/A	Sold -100.00% shares Q3 2022
Biotechnology Novavax, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $17.61 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$17.61	N/A	Sold -100.00% shares Q3 2022
Health Information Services Science 37 Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $9.43 Current price: $0.61 P/L: -93.53% Sold -100.00% shares Q3 2022	share	0.00%	0	$9.43	$0.61	-93.53%	Sold -100.00% shares Q3 2022
Biotechnology Silverback Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.87 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.87	N/A	Sold -100.00% shares Q3 2022

Showing TOP 85 AFFINITY ASSET ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of AFFINITY ASSET ADVISORS, LLC?

The biggest position of the AFFINITY ASSET ADVISORS, LLC is SPDR S&P 500 ETF Trust (SPY) with 24.92% portfolio share worth of 89.3M US dollars.

Top 5 AFFINITY ASSET ADVISORS's holdings represent 41.2% of the portfolio:

SPDR S&P 500 ETF Trust (SPY) – 24.92%
Establishment Labs Holdings Inc. (ESTA) – 4.98%
Chinook Therapeutics, Inc. (KDNY) – 4.47%
Global Blood Therapeutics, Inc. (GBT) – 3.61%
iShares Russell 2000 ETF (IWM) – 3.22%

Who is the portfolio manager of AFFINITY ASSET ADVISORS, LLC?

The portfolio manager of the AFFINITY ASSET ADVISORS, LLC is .

What is the total asset value of the AFFINITY ASSET ADVISORS, LLC portfolio?

AFFINITY ASSET ADVISORS, LLC total asset value (portfolio value) is 358.28M US dollars.

Who is ?

is the portfolio manager of the AFFINITY ASSET ADVISORS, LLC.

What is (AFFINITY ASSET ADVISORS, LLC) fund performance?

AFFINITY ASSET ADVISORS's quarterly performance is +4.07%, annualy -49.49%.

What is the AFFINITY ASSET ADVISORS, LLC CIK?

AFFINITY ASSET ADVISORS's Central Index Key is 0001773195 .